AMRN Amarin Corp Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMRN

Price (delayed)

$4.60

Market cap

$1.82B

P/E Ratio

N/A

Dividend/share

N/A

EPS

$0

Enterprise value

$1.53B

Sector: Healthcare
Industry: Biotechnology
Website: http://www.amarincorp.com/

Highlights

AMRN's net income has soared by 105% from the previous quarter and by 105% YoY
The company's EPS has surged by 100% QoQ and by 100% YoY
The revenue is up by 18% year-on-year but it is down by 2.1% since the previous quarter
AMRN's quick ratio is down by 9% year-on-year and by 3.7% since the previous quarter

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
394.77M
Market cap
$1.82B
Enterprise value
$1.53B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.85
Price to sales (P/S)
3.02
EV/EBIT
191.33
EV/EBITDA
152.4
EV/Sales
2.54
Earnings
Revenue
$601.24M
EBIT
$8M
EBITDA
$10.04M
Free cash flow
-$44.58M
Per share
EPS
$0
Free cash flow per share
-$0.11
Book value per share
$1.61
Revenue per share
$1.52
TBVPS
$2.44
Balance sheet
Total assets
$990.25M
Total liabilities
$355.64M
Debt
$9.02M
Equity
$634.61M
Working capital
$604.75M
Liquidity
Debt to equity
0.01
Current ratio
2.86
Quick ratio
2.06
Net debt/EBITDA
-28.48
Margins
EBITDA margin
1.7%
Gross margin
79.2%
Net margin
0.2%
Operating margin
0.5%
Efficiency
Return on assets
0.1%
Return on equity
0.1%
Return on invested capital
1.9%
Return on capital employed
1.2%
Return on sales
1.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
1.32%
1 week
-9.63%
1 month
-23.97%
1 year
-38.83%
YTD
-5.93%
QTD
-25.93%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$601.24M
Gross profit
$476.28M
Operating income
$3.04M
Net income
$927,000
Gross margin
79.2%
Net margin
0.2%
AMRN's operating margin has surged by 116% since the previous quarter and by 110% year-on-year
AMRN's operating income has soared by 115% since the previous quarter and by 112% year-on-year
AMRN's net margin has surged by 107% since the previous quarter and by 105% year-on-year
AMRN's net income has soared by 105% from the previous quarter and by 105% YoY

Growth

What is Amarin's growth rate over time

Valuation

What is Amarin stock price valuation
P/E
N/A
P/B
2.85
P/S
3.02
EV/EBIT
191.33
EV/EBITDA
152.4
EV/Sales
2.54
The company's EPS has surged by 100% QoQ and by 100% YoY
AMRN's P/B is 19% below its last 4 quarters average of 3.5
The equity is up by 8% year-on-year
The P/S is 68% less than the 5-year quarterly average of 9.3 and 18% less than the last 4 quarters average of 3.7
The revenue is up by 18% year-on-year but it is down by 2.1% since the previous quarter

Efficiency

How efficient is Amarin business performance
The company's return on sales has surged by 154% QoQ and by 138% YoY
The ROIC has soared by 153% QoQ and by 112% YoY
Amarin's ROA has soared by 105% from the previous quarter and by 104% YoY
AMRN's ROE has soared by 103% from the previous quarter and by 103% YoY

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time
AMRN's total assets is 178% greater than its total liabilities
AMRN's quick ratio is down by 9% year-on-year and by 3.7% since the previous quarter
The current ratio has grown by 9% YoY
AMRN's debt is 99% smaller than its equity
Amarin's debt to equity has plunged by 88% YoY
AMRN's debt has dropped by 81% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.